Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch
  

Osi Pharmaceuticals Llc patents

Recent patent applications related to Osi Pharmaceuticals Llc. Osi Pharmaceuticals Llc is listed as an Agent/Assignee. Note: Osi Pharmaceuticals Llc may have other listings under different names/spellings. We're not affiliated with Osi Pharmaceuticals Llc, we're just tracking patents.

ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "O" | Osi Pharmaceuticals Llc-related inventors




Date Osi Pharmaceuticals Llc patents (updated weekly) - BOOKMARK this page
09/28/17Pulse dosing regimen and methods of treatment
06/09/16Biological markers predictive of anti-cancer response to epidermal growth factor receptor kinase inhibitors
03/05/15Processes for the preparation of isothiazole derivatives
10/03/13Macrocyclic kinase inhibitors
10/03/13Preparation of c-pyrazine-methylamines
09/26/13Fused bicyclic kinase inhibitors
09/05/13Amino pyrimidine anticancer compounds
08/15/13Biological markers predictive of anti-cancer response to kinase inhibitors
07/25/136,6-bicyclic ring substituted heterobicyclic protein kinase inhibitors
06/27/13Fused bicyclic mtor inhibitors
05/30/13Pet imaging
03/21/13Fused bicyclic kinase inhibitors
01/03/13Combination anti-cancer therapy
12/27/12Substituted-5-aminopyrrolo/pyrazolopyridines
11/29/12Use of emt gene signatures in cancer drug discovery, diagnostics, and treatment
08/30/12Deuterated tyrosine kinase inhibitors
08/23/12Biological markers predictive of anti-cancer response to insulin-like growth factor-1 receptor kinase inhibitors in hepatocellular carcinoma
08/16/12Combined treatment with an egfr kinase inhibitor and an agent that sensitizes tumor cells to the effects of egfr kinase inhibitors
08/02/126,6-bicyclic ring substituted heterobicyclic protein kinase inhibitors
07/26/12Combination anti-cancer therapy
06/07/12Biological markers predictive of anti-cancer response to epidermal growth factor receptor kinase inhibitors
05/24/12Mtor inhibitor and angiogenesis inhibitor combination therapy
05/17/12Biological markers predictive of anti-cancer response to insulin-like growth factor-1 receptor kinase inhibitors
04/26/12Biological markers predictive of anti-cancer response to insulin-like growth factor-1 receptor kinase inhibitors
03/29/126,6-bicyclic ring substituted heterobicyclic protein kinase inhibitors
02/16/12Preparation of c-pyrazine-methylamines
11/17/11Fused bicyclic kinase inhibitors
09/15/11Substituted pyrrolo[2,3-b]-pyridines and -pyrazines
09/08/11Fused bicyclic mtor inhibitors







ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Osi Pharmaceuticals Llc in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Osi Pharmaceuticals Llc with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###




';